Faecal specimen container IVD, no additive - UK MHRA Medical Device Registration

Faecal specimen container IVD, no additive is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 95839. The device is manufactured by Meridian Bioscience Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Launch Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Faecal specimen container IVD, no additive

MHRA Device ID: 95839•Ref: 95839

Device Type

In Vitro Diagnostic Device

Devices

Faecal specimen container IVD, no additive

Type

IVD General

Date Registered

Apr 11, 2024

Last Updated

Apr 5, 2024

Manufacturer Information

Name

Meridian Bioscience Inc.

Address

3471 River Hills Drive

Cincinnati, OH, United States

Created Date

Aug 18, 2021

Authorized Representative

Name

Launch Diagnostics Limited

Relationship Type

UK Responsible Person

Address

Unit 20 Ash Way Thorp Arch Estate

Wetherby, England, United Kingdom

Postcode: LS23 7FA

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Meridian Bioscience Inc. (10)

Other Products from Same Authorized Representative (10)

Faecal specimen container IVD, no additive - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Influenza A/B virus antigen IVD, kit, rapid ICT, clinical

Total cortisol IVD, reagent

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Clostridium difficile antigen IVD, antibody

Multiple gastrointestinal virus antigen IVD, kit, rapid ICT, clinical

Mycobacterium tuberculosis complex species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

Prothrombin time (PT) IVD, reagent

Multiple Campylobacter species antigen IVD, kit, enzyme immunoassay (EIA)

Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical

Beta-haemolytic Group A Streptococcus nucleic acid IVD, control

Bordetella pertussis nucleic acid IVD, control

Bordetella pertussis nucleic acid IVD, kit, nucleic acid technique (NAT)

Clostridium difficile antigen IVD, kit, enzyme immunoassay (EIA)

Cryptococcus neoformans antigen IVD, kit, rapid agglutination, clinical

Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)

Cytomegalovirus (CMV) nucleic acid IVD, kit, nucleic acid technique (NAT)

Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)

Candida albicans nucleic acid IVD, kit, nucleic acid technique (NAT)

Cardiovascular disease genetic risk IVD, kit, nucleic acid technique (NAT)

Chikungunya virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Hepatitis B virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Hepatitis C virus nucleic acid IVD, kit, nucleic acid technique (NAT)

HIV1 genotyping IVD, kit, nucleic acid technique (NAT)

Human herpesvirus 6 (HHV6) nucleic acid IVD, kit, nucleic acid technique (NAT)

Human papillomavirus (HPV) high risk strain nucleic acid IVD, kit, nucleic acid technique (NAT)

Influenza A virus H1N1 subtype (swine influenza) nucleic acid IVD, kit, nucleic acid technique (NAT)

Adenovirus nucleic acid IVD, kit, nucleic acid technique (NAT)